Crystalline cephem acid addition salts and process for their preparation
Patent 5409918 Issued on April 25, 1995. Estimated Expiration Date: August 21, 2012. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
Crystalline cephem acid addition salts of the general formula II ##STR1## pharmaceutical preparations effective against bacterial infections which contain such cephem derivatives, processes for the preparation of the cephem derivatives and the pharmaceutical preparations, and the use of the cephem derivatives for combating bacterial infections.
Other References
Chemical Abstracts vol. 115(8):78903(j) (1991)
Chemical Abstracts vol. 105(19):164392(s) (1986)
In Vivo Evaluation of Tigemonam, a Novel Oral Monobactam, Junius M. Clark et al., Antimicrobial Agents and Chemotherapy, vol. 31, No. 2, Feb. 1987, pp. 226-229
Pharmacokinetic and In Vivo Studies with Azithromycin (CP-62,993), a New Macrolide with an Extended Half-Life and Excellent Tissue Distribution, Girard et al., Antimicrobial Agents and Chemotherapy, vol. 31, No. 12, Dec. 1987, pp. 1948-1954
The Relationship of Absorption Characteristics and Gastrointestinal Side Effects of Oral Antimicrobial Agents, Grossman, Clinical Therapeutics, vol. 13, No. 1, pp. 189-193 (1991)
Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2, Dantzig et al., Biochimica et Biophysica Acta, 1027, pp. 211-217 (1990)
Stereochemical Considerations in Drug Absorption, Disposition and Pharmacokinetics, Hutt, Drug Chirality, 24th and 25th Oct. 1990
Studies on Orally Active Cephalosporin Esters. IV.1), Miyauchi et al., Chem. Pharm. Bull. 32(12), pp. 3272-3276 (1989)
Studies on Orally Active Cephalosporin Esters. II.1), Miyauchi et al., Chem. Pharm. Bull. 37(9), pp. 2369-2374 (1989)
Synthesis and Mechanisms of Decomposition of Some Cephalosporin Prodrugs, Saab et al., Journal of Pharmaceutical Sciences, vol. 79, No. 9, (1990)
Orally Active 1-(Cyclohexyloxycarbonyloxy)Alkyl Ester Prodrugs of Cefotiam Nishimura et al., The Journal of Antibiotics, vol. XL, No. 1, pp. 81-90 (1986)
Angewandte Chemie, vol. 24, No. 3, Mar. 1985, pp. 180-202
Pharmacokinetics of FK482, A New Orally Active Cephalosporin, in Animals, Sakamoto et al., The Journal of Antibiotics, vol. XLI, No. 12, pp. 1896-1905 (1988
August 21, 2012. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
